Supplementary Figure 3 from Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab

Abstract

<p>Daratumumab-mediated CD38 reduction on NK cells is abrogated by depleting monocytes from PBMCs.</p>